CompletedNot Applicable

Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's

United States130 participantsStarted 2023-01-31

Plain-language summary

Objectives To 1) examine the ability of the STRIDE (Simplification of Treatment Regimens and Individualized Diabetes Education) educational program to increase deprescribing of high hypoglycemia risk glucose-lowering medications (HRMs) among long term care facility (LTCF) residents with ADRD, 2) assess key implementation constructs (secondary outcomes) of the STRIDE program, including acceptability, appropriateness, and feasibility, and 3) validate the primary HRM use outcome measure.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical staff at the LTCF (MDs, PAs, NPs, clinical pharmacists) - (Targeted providers for STRIDE program) * Clinical staff that participated in the STRIDE program (Providers doing stakeholder exit interviews) Exclusion Criteria: * Consistent with the pragmatic nature of the trial, there are no exclusion criteria.

What they're measuring

Change in proportion of long term care facility (LTCF) residents with Alzheimer's disease adn related dementias (ADRD) and diabetes with high risk medications (HRM) use

Timeframe: Baseline vs 6 months

Trial details

NCT IDNCT05535478

SponsorJoslin Diabetes Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-14

View on ClinicalTrials.gov More Diabetes trials